Hemab Therapeutics Holdings, Inc. Common Stock (COAG) Live Share Price, Invest From India

Hemab Therapeutics Holdings, Inc. Common Stock Stock Performance

as on May 5, 2026 at 2:08 am IST

Day's Low
Day's High
$28.52
Day's Price Range
$31.80
$29.20
2.33%
Downside
8.90%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$29.20
100.00%
Downside
-100.00%
Upside

Hemab Therapeutics Holdings, Inc. Common Stock share price movements today

Previous Close: $34.00
Open: $30.87
Volume: 214.6K
Day's Low - High: $28.52 - $31.80

Hemab Therapeutics Holdings, Inc. Common Stock Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Hemab Therapeutics Holdings, Inc. Common Stock Stock Fundamentals & Key Indicators

Check Hemab Therapeutics Holdings, Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.4B

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-46.99%

Hemab Therapeutics Holdings, Inc. Common Stock stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Hemab Therapeutics Holdings, Inc. Common Stock with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Hemab Therapeutics Holdings, Inc. Common Stock	NA	$1.4B	NA	NA	0.00%

Hemab Therapeutics Holdings, Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

	Dec 2024	Dec 2025
Total Revenue	-	-
Gross Profit	-	-
Operating Income	-50	-70
EBITDA	-	-
Interest Expense	-	-
Depreciation	0	0
Income Before Tax	-48	-64
Income Tax Expense	-	-
Net Income	-48	-63
Net Profit Margin	0.00%	0.00%

Hemab Therapeutics Holdings, Inc. Common Stock Annual Cash Flow

All numbers in Millions USD

	Dec 2025
Net Income	-63
Operating Cash Flow	-61
Investing Cash Flow	-
Financing Cash Flow	156
Change in Cash	13

About Hemab Therapeutics Holdings, Inc. Common Stock

Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience in United States of America and Denmark. Its products includes (HMB-001), is a bispecific antibody currently in Phase 1/2 clinical development for the prophylactic treatment of Glanzmann thrombasthenia and Phase 2 clinical development for the prophylactic treatment of Factor VII deficiency; and second clinical-stage asset, HMB-002, is a monovalent antibody in Phase 1/2 clinical development for the subcutaneous prophylactic treatment of Von Willebrand disease. It also advances multiple preclinical and discovery-stage assets. The company was founded in 2020 and is based in Cambridge, Massachusetts.

Organisation	Hemab Therapeutics Holdings, Inc. Common Stock
Headquarters	101 Main Street, Cambridge, MA, United States, 02142
Industry	Biotechnology
CEO	Dr. Benny Sorensen M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Hemab Therapeutics Holdings, Inc. Common Stock

Name	Title
Ms. Cecile Bonvoisin M.Sc.	Senior Vice President of CMC & Manufacturing
Ms. Tara O'Meara	Senior Vice President of Development Operations
Dr. Benny Sorensen M.D., Ph.D.	President, CEO & Director
Dr. Catherine Madigan M.D.	Chief Medical Officer
Dr. Ananthram Murthy M.Sc., Ph.D.	Chief Operating Officer

FAQs

What is Hemab Therapeutics Holdings, Inc. Common Stock share price today?

Hemab Therapeutics Holdings, Inc. Common Stock share price today is $29.2 as on May 4, 2026 at 8:38 pm IST. Hemab Therapeutics Holdings, Inc. Common Stock share today touched a day high of $31.8 and a low of $28.52.

What is the 52 week high and 52 week low for Hemab Therapeutics Holdings, Inc. Common Stock share?

Hemab Therapeutics Holdings, Inc. Common Stock share touched a 52 week high of $ on January 1, 1970 and a 52 week low of $ on January 1, 1970. Hemab Therapeutics Holdings, Inc. Common Stock stock price today i.e. May 4, 2026 at 8:38 pm IST is trending at $29.2,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Hemab Therapeutics Holdings, Inc. Common Stock's market capitalisation today?

Hemab Therapeutics Holdings, Inc. Common Stock market capitalisation is $0.00T as on May 4, 2026 at 8:38 pm IST.

How to invest in Hemab Therapeutics Holdings, Inc. Common Stock Stock (COAG) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Hemab Therapeutics Holdings, Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Hemab Therapeutics Holdings, Inc. Common Stock Shares that will get you 0.0514 shares as per Hemab Therapeutics Holdings, Inc. Common Stock share price of $29.2 per share as on May 4, 2026 at 8:38 pm IST.

What is the minimum amount required to buy Hemab Therapeutics Holdings, Inc. Common Stock Stock (COAG) from India?

Indian investors can start investing in Hemab Therapeutics Holdings, Inc. Common Stock (COAG) shares with as little as ₹95.067 or $1 (as of May 4, 2026 at 8:38 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹950.67 in Hemab Therapeutics Holdings, Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on May 4, 2026 at 8:38 pm IST). Based on Hemab Therapeutics Holdings, Inc. Common Stock share’s latest price of $29.2 as on May 4, 2026 at 8:38 pm IST, you will get 0.3425 shares of Hemab Therapeutics Holdings, Inc. Common Stock. Learn more about fractional shares .